Cyclosporine induces cancer progression by a cell-autonomous mechanism

Nature

Volumn 397, Issue 6719, 1999, Pages 530-534

  Hojo, Minoru ^a,b   Morimoto, Takashi ^c   Maluccio, Mary ^a   Asano, Tomohiko ^d   Morimoto, Kengo ^b   Lagman, Milagros ^a   Shimbo, Toshikazu ^b   Suthanthiran, Manikkam ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER; CANCER CELL CULTURE; CANCER GROWTH; CELL MOTILITY; CELL TRANSFORMATION; IMMUNITY; IMMUNOSURVEILLANCE; NONHUMAN; ORGAN TRANSPLANTATION; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES; CARCINOGENS; CARCINOMA, RENAL CELL; CELL ADHESION; CELL DIVISION; CELL MOVEMENT; CELL SIZE; CELL TRANSFORMATION, NEOPLASTIC; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MICE; MICE, SCID; MICROSCOPY, ELECTRON, SCANNING; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PHENOTYPE; PSEUDOPODIA; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0033545299     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/17401     Document Type: Article

References (30)

1. Penn, I. Cancers following cyclosporine therapy. Transplantation 43, 32-35 (1987).
2. Yokoyama, I., Carr, B. Saitsu, H., Iwatsuki, S. & Seared T. E. Accelerated growth rates of recurrent hepatocellar carcimona after liver transplantation. Cancer 68, 2095-2100 (1991).
3. London, N. J., Farmerry, S. M., Will, E. J., Davison, A. M. & Lodge, J. P. A. Risk of neoplosia in renal transplant patients. Lancet 346, 403-406 (1995).
4. Suthanthiran, M. & Strom, T. B. Renal transplantation, N. Engl. J. Med. 331, 365-376 (1994).
5. Kaban, B. D. Cyclosporine, N. Engl. J. Med. 321, 1723-1738 (1989).
6. Shimizu, T., Martin, M. S., Pelletier, H., Issg P. & Martin, F. Effects of cyclosporin A on progressive and regressive tumors induced by lines derived from a single colors carcinoma chemically induced in the rat. Immunology 138; 4-415 (1983).
7. Van de Vrie, W., , R. L. Marquet & Eggerman A. M. C M., A. enhance regional metatasis of the CC531 rat colon tumor, J. Garet. Bv. Clin. 132, 21-24 (1997).
8. Van der Elst, J. et al. Quantitative study of Liver from colon cancer 132, 21-24 (1997).
9. Masuhara, M., Ogasawara, H., Katyal, S. L., Nakamura, T. & Shinozuka, H. Cyclosporine stimulates hepatocyte proliferation and accelerates development of heptocellular carcinomas in rats. Carcinogenesis 14, 1579-1584 (1993).
10. Li, B. et al. Differential regulation of transforming growth factor-β and interleukin 2 genes in human T cells: Demonstration by usage of novel competitor DNA constructs in quantitative polymerase chain reaction, J. Exp. Med. 174, 1259-1262 (1991).
11. Khanna, A., Li., B., Stenzel, K. H & Suthanthiran, M. Regulation of new DNA synthesis in mammalian cells by cyclosporine. Transplantation 57, 577-582 (1994).
12. Welch. D. R., Fabra, A. & Nakajima, M. Transforming growth factor-β stimulates mammary adenocarcinoma cell invasion and metastic potential. Proc. Natl. Acad Sci. USA 87, 7678-7682 (1990).
13. Caulin, C., Scholl, E. G., Frontelo, P. Gamallo,. C. & Quntanilla, M. Chronic exposure of cultured transformed mouse epidermal cells to transforming growth factor-β induces an epithelial-mesenchymal transdiffentiation and a spindle tumoral phenotype. Cell Growth Differ. 6, 1027-1035 (1995).
14. 1 on human pulmonary adenocarcinoma cell adhesion, motility, and invasion in vitro. J. Natl Cancer Inst. 84, 523-527 (1992).
15. Dasch, J. R., Pace, D. R., Waigell, W. Inenaga, D. & Ellingsworth, L. Monoclonal antibodies recognizing transforming growth factor-β. Bioactivity neutralization and transforming growth factor-β. affinity purification. J. Immunol. 142, 1536-1541 (1989).
16. Wolf, G., Thaiss, F. & Stahl, R. A. Cyclosporine stimulates expression of transforming growth factor-β in renal cells. Posible merchanism of cyclosporine's anti-proliferative effects. Transplantation 60, 237-241 (1995).
17. Guirguis, R., Margulies, I., Taraboletti, G., Schiffmann, E. & Liotta, L. Cytokine-induced pseudopodial protrusion is coupled to tumor cell migration. Nature 329, 261-263 (1987).
18. Couchman, J. R., Lenn, M. & Rees, D. A. Coupling of cytoskeletal functions for fibroblast locomotion. Eur. J. Cell Biol. 36, 182-194 (1985).
19. Freeman, V. H. & Shin, S. Cellular tumorigenecity in nude mice: Correlation with cell growth in semisolid medium. Cell 3, 355-359 (1974).
20. Messague, J. Transforming growth factor-β family. Annu. Rev. Cell Biol. 6, 597-641 (1990).
21. Murphy, G. P. & Hrushesky, W. J. A murine renol cell carcinoma. J. Natl Cancer Inst 50, 1013-1025 (1973).
22. Bertram, J. S. & Janik, P. Establishment of a cloned line of Lewis Lung Carcinoma cells adapted to cell culture. Cancer lett. 11, 63-73 (1980).
23. Bubenil, J et al. Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen. Int. J. Cancer 11, 765-773 (1973).
24. Mosier, D. E., Stell, K. L., Gulizia, R. J., Torbett, B. E. & Gilmore, G. L. Homozygous scid/scid:beige/ beige mice have low levels of spontaneous or reenatal T cell-induced B cell generation. J. Exp. Med. 177, 191-194 (1993).
25. 1 ihibits the formation of benign skin tumor, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86, 531-542 (1996).
26. Atrega, C. I. et al. Anti-transforming growth factor (TGF)-β antibodies inhibit breast cancer cell tumorigenicity and increase mouse spices natural killer cell activity. J. Clin. Invest. 92, 2569-2576 (1993).
27. 1 cDNA escapes immune survillance. Proc. Natl Acad. Sci. USA 87, 1486-1490 (1990).
28. 1. J. Cell Biol. 118, 715-726 (1992).
29. Cohen-Gould, L., Robinson, T. F. & Factor, S. M. Intrinsic connective tissue abnormalities in the heart muscle of cardiomyopathy Syrian hamsters. Am. J. Pathol. 127; 327-334 (1987).
30. Asano, T., Khanna, A., Lagman, M., Li, B. & Suthanthir, M. Immunostimulatory therapy with anti-CD3 monoclonal antibodies and recombinant interleukin-2: Heightened in vivo expression of mRNA encoding cytotoxic attack molecules and immunoregulatory cytokines and regression of murine renal cell carcinoma. J. Urol. 157, 2396-2401 (1997).